{"id":"W4392481691","doi":"10.1016/j.ebiom.2024.105043","title":"A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies","year":2024,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"H2020 Marie Skłodowska-Curie Actions; Astellas Pharma; Oncolytics Biotech; Incyte; Gilead Sciences; GlaxoSmithKline; Fundación Científica Asociación Española Contra el Cáncer; Veracyte; Daiichi Sankyo Europe; European Commission; Breast Cancer Research Foundation; Instituto de Salud Carlos III; Amgen; Pfizer; Les Laboratories Pierre Fabre; Fundación Fero; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Triple-negative breast cancer; Medicine; Oncology; Internal medicine; Breast cancer; Immune system; Cohort; Stage (stratigraphy); Survival analysis; Proportional hazards model; Cancer; Immunology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01628967,0.001379826,0.004442228,0.005400263,0.000493853,0.001974219,0.0008480755,0.0009792093,0.002024673],"category_scores_gemma":[0.01592551,0.0006300669,0.01476427,0.005204682,0.0004003293,0.0007316959,0.001712998,0.0005887249,0.0002559227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005254786,"about_ca_system_score_gemma":0.0008425062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002301321,"about_ca_topic_score_gemma":0.00378651,"domain_scores_codex":[0.989256,0.004810703,0.002156226,0.002229622,0.00118365,0.0003637948],"domain_scores_gemma":[0.9840708,0.00933017,0.003235303,0.001614338,0.001405147,0.000344227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.007971344,0.00003871628,0.3518242,0.0129797,0.607626,0.0002065239,0.0001513472,0.0008030607,0.001635633,0.0001288667,0.0008822993,0.01575224],"study_design_scores_gemma":[0.000715457,0.000675689,0.2795528,0.001559726,0.712817,0.0003852966,0.0001878277,0.0006554823,0.0004800043,0.0003067465,0.002623891,0.00004010808],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5510838,0.42915,0.005674857,0.0004304235,0.0002445033,0.0004450868,0.01118182,0.0001472663,0.001642228],"genre_scores_gemma":[0.975497,0.01767797,0.001594075,0.0002072597,0.00009433403,0.0003749244,0.004227357,0.00005440036,0.000272721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01628967,"threshold_uncertainty_score":0.08614904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01436953566838358,"score_gpt":0.3121454258346046,"score_spread":0.297775890166221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}